Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACRS | ZTS | TAK | NBIX | UTHR |
| Company | Aclaris Therapts | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.1900 | 159.64 | 13.14 | 138.07 | 236.28 |
| High | 1.2300 | 162.13 | 13.23 | 140.47 | 237.76 |
| Low | 1.1900 | 158.92 | 13.08 | 137.34 | 233.31 |
| Last | 1.2100 | 159.24 | 13.08 | 137.54 | 234.33 |
| Change | -0.0100 | -0.46 | -0.09 | -1.35 | -3.93 |
| % Change | -0.82% | -0.29% | -0.68% | -0.97% | -1.65% |
| Volume | 930,300 | 3,647,800 | 909,500 | 966,500 | 619,500 |
| 20-Day Average Volume | 744,760 | 4,491,240 | 1,710,490 | 752,715 | 480,680 |
| Previous Close | 1.2200 | 159.70 | 13.17 | 138.89 | 238.26 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2100 | 156.71 | 13.34 | 136.33 | 235.26 |
| 20-Day Raw Stochastic | 43.75% | 58.72% | 9.74% | 49.83% | 48.33% |
| 20-Day Relative Strength | 48.94% | 44.70% | 35.94% | 51.44% | 50.16% |
| Weighted Alpha | -44.44 | -17.09 | -22.52 | +40.69 | +8.58 |
| Today's Opinion | 48% Sell | 72% Sell | 100% Sell | 80% Buy | 64% Buy |
| Previous Opinion | 24% Sell | 72% Sell | 100% Sell | 80% Buy | 80% Buy |
| Last Month's Opinion | 48% Sell | 56% Sell | 72% Sell | 100% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.82% since 04/23/24 | +6.47% since 04/23/24 | -2.24% since 04/23/24 | -1.82% since 04/23/24 | -0.06% since 04/23/24 |
| Low | 1.1400 on 04/25/24 | 148.75 on 04/24/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.27 on 04/24/24 |
| High | 1.2350 on 04/24/24 | 165.04 on 04/29/24 | 13.33 on 04/24/24 | 144.70 on 04/24/24 | 241.00 on 04/24/24 |
| 1-Month | |||||
| %Chg | -2.42% since 03/28/24 | -5.89% since 03/28/24 | -5.83% since 03/28/24 | -0.28% since 03/28/24 | +2.01% since 03/28/24 |
| Low | 1.1400 on 04/25/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 221.53 on 04/01/24 |
| High | 1.3200 on 04/01/24 | 169.49 on 04/01/24 | 13.78 on 04/01/24 | 145.00 on 04/23/24 | 241.37 on 04/11/24 |
| 3-Month | |||||
| %Chg | unch since 01/30/24 | -16.82% since 01/30/24 | -10.04% since 01/30/24 | -3.18% since 01/30/24 | +8.98% since 01/30/24 |
| Low | 1.0500 on 02/07/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 1.5100 on 03/06/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 250.89 on 03/26/24 |
| 6-Month | |||||
| %Chg | -73.58% since 10/30/23 | +1.43% since 10/30/23 | -2.10% since 10/30/23 | +28.39% since 10/30/23 | +6.21% since 10/30/23 |
| Low | 0.5902 on 11/13/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 5.7050 on 11/06/23 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 258.31 on 12/14/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 86,943 | 73,040,232 | 41,680,904 | 13,820,528 | 11,212,275 |
| Shares Outstanding, K | 71,265 | 457,359 | 3,164,837 | 99,507 | 47,059 |
| Annual Sales | 31,250,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -88,480,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 17,570,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -1,490,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 0.22 | 0.85 | 0.53 | 0.25 | 0.52 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 02/27/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.44 on 02/07/24 | 4.36 on 02/21/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.78 | 6.68 | 56.19 | 11.79 |